current and emerging prognostic factors for mds/mpn
Published 1 year ago • 199 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
4:28
current and emerging treatment options for mds
-
2:18
prognostic factors and mutations in mds
-
1:30
the prognostic value of patient-reported outcomes in mds
-
1:51
factors driving the transformation of chip to mds
-
1:55
mds genomics: diagnosis and prognosis
-
2:16
current and future treatment approaches for hr-mds
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
1:26
incidence and risk factors associated with vod/sos in younger vs older adults after sct
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment
-
3:49
factors influencing mpn progression
-
1:14
an overview of the current and future treatment landscape for mpns
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
5:36
mcl0208: identification of novel genomic prognostic factors
-
1:20
the current standard of care for patients with lower-risk mds
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:06
the prognostic value of self-reported fatigue on overall survival in patients with mds
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
1:16
state of the art: mds